These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33877294)

  • 1. 13q12.2 deletions and FLT3 overexpression in acute leukemias.
    Poubel CP; Boroni M; Emerenciano M
    Blood Adv; 2021 Apr; 5(8):2075-2078. PubMed ID: 33877294
    [No Abstract]   [Full Text] [Related]  

  • 2. 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.
    Yang M; Safavi S; Woodward EL; Duployez N; Olsson-Arvidsson L; Ungerbäck J; Sigvardsson M; Zaliova M; Zuna J; Fioretos T; Johansson B; Nord KH; Paulsson K
    Blood; 2020 Aug; 136(8):946-956. PubMed ID: 32384149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletions in BCP-ALL result in a TAD more FLT3.
    Spencer DH
    Blood; 2020 Aug; 136(8):919-920. PubMed ID: 32818246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages.
    Birg F; Courcoul M; Rosnet O; Bardin F; Pébusque MJ; Marchetto S; Tabilio A; Mannoni P; Birnbaum D
    Blood; 1992 Nov; 80(10):2584-93. PubMed ID: 1384791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias.
    Vela-Ojeda J; Cardenas PV; Garcia-Ruiz Esparza MA; Montiel Cervantes LA; Chavez JG; Caballero AH; Majluf-Cruz A; Vega-López A; Reyes-Maldonado E
    Arch Med Res; 2021 Feb; 52(2):217-223. PubMed ID: 33109387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia.
    Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson RJ; Nachman JB; Reaman GH; Lange BJ; Steinherz PG; Bostrom BC; Gaynon PS; Uckun FM
    J Clin Oncol; 2000 Nov; 18(22):3837-44. PubMed ID: 11078497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation t(8;13)(p11;q11-12) in stem cell leukemia/lymphoma of T-cell and myeloid lineages.
    Naeem R; Singer S; Fletcher JA
    Genes Chromosomes Cancer; 1995 Feb; 12(2):148-51. PubMed ID: 7535088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.
    Paietta E; Ferrando AA; Neuberg D; Bennett JM; Racevskis J; Lazarus H; Dewald G; Rowe JM; Wiernik PH; Tallman MS; Look AT
    Blood; 2004 Jul; 104(2):558-60. PubMed ID: 15044257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
    Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLT3 mutations in childhood acute lymphoblastic leukemia.
    Armstrong SA; Mabon ME; Silverman LB; Li A; Gribben JG; Fox EA; Sallan SE; Korsmeyer SJ
    Blood; 2004 May; 103(9):3544-6. PubMed ID: 14670924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias.
    Han X; Bueso-Ramos CE
    Am J Clin Pathol; 2007 Apr; 127(4):528-44. PubMed ID: 17369128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations involving 13q12 approximately q14 are frequent secondary events in childhood acute lymphoblastic leukemia.
    Kovacs BZ; Niggli FK; Betts DR
    Cancer Genet Cytogenet; 2004 Jun; 151(2):157-61. PubMed ID: 15172754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.
    Stam RW; den Boer ML; Schneider P; Meier M; Beverloo HB; Pieters R
    Haematologica; 2007 Nov; 92(11):1565-8. PubMed ID: 18024407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fms-like tyrosine kinase 3 mutations in childhood acute leukemias and their association with prognosis.
    Karabacak BH; Erbey F; Bayram I; Yilmaz S; Acipayam C; Kilinç Y; Tanyeli A
    Asian Pac J Cancer Prev; 2010; 11(4):923-7. PubMed ID: 21133602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges.
    Sternberg DW; Licht JD
    Curr Opin Hematol; 2005 Jan; 12(1):7-13. PubMed ID: 15604885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of acute lymphocytic leukemias to the purine antagonist 6-mercaptopurine.
    LAW LW; TAORMINA V; BOYLE PJ
    Ann N Y Acad Sci; 1954 Dec; 60(2):244-50. PubMed ID: 14350530
    [No Abstract]   [Full Text] [Related]  

  • 17. Classification of acute leukemias.
    Brunning RD
    Semin Diagn Pathol; 2003 Aug; 20(3):142-53. PubMed ID: 14552428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.
    Kohlmann A; Schoch C; Dugas M; Schnittger S; Hiddemann W; Kern W; Haferlach T
    Leukemia; 2005 Jun; 19(6):953-64. PubMed ID: 15815718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effects of a guanine a analog on acute lymphoid leukemias of mice.
    LAW LW
    Cancer Res; 1950 Mar; 10(3):186-90. PubMed ID: 15405698
    [No Abstract]   [Full Text] [Related]  

  • 20. p16INK4 gene deletions in childhood acute lymphoblastic leukemias.
    Iolasceon A; Del Giudice EM; Perrotta S; Russo GL; Oliva A; Mercurio C; Della Ragione F
    Leuk Res; 1995 Nov; 19(11):883-5. PubMed ID: 8551807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.